The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study

The aim of this study was to evaluate the effect of upfront combination therapy with ambrisentan and tadalafil on left ventricular (LV) and right ventricular (RV) function in patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH). LV and RV peak longitudinal and circum...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pulm Circ
Egile Nagusiak: Sato, Takahiro, Ambale-Venkatesh, Bharath, Lima, Joao A.C., Zimmerman, Stefan L., Tedford, Ryan J., Fujii, Tomoki, Hulme, Olivia L., Pullins, Erica H., Corona-Villalobos, Celia P., Zamanian, Roham T., Minai, Omar A., Girgis, Reda E., Chin, Kelly, Khair, Rubina, Damico, Rachel L., Kolb, Todd M., Mathai, Stephen C., Hassoun, Paul M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018906/
https://ncbi.nlm.nih.gov/pubmed/29251556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045893217748307
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak